SELLAS Life Sciences Group, Inc. (SLS)

2.815 +0.04 (+1.62%) USD  |  NASDAQ  |  Dec 24, 12:01
More

SELLAS Life Sciences Group Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Geron Corp. Upgrade
GT Biopharma, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. --